Failure of serial human immunodeficiency virus type 1 DNA polymerase chain reactions to identify human immunodeficiency virus type 1 clade A/G

Pediatric Infectious Disease Journal

Volumn 24, Issue 2, 2005, Pages 183-184

  Obaro, Stephen K ^a   Losikoff, Phyllis ^a   Harwell, Joseph ^a   Pugatch, David ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; COTRIMOXAZOLE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MALE; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS IDENTIFICATION; VIRUS LOAD;

ADOLESCENT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION, VERTICAL; FALSE NEGATIVE REACTIONS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; VIRAL LOAD;

EID: 13844276187     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000151040.57772.40     Document Type: Article

References (12)

1. Dunn DT, Brandt CD, Kirvine A, et al. Sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS. 1995;9:F7-F11.
2. Barlow KL, Tosswill JHC, Parry JV, Clewley JP. Performance of the Amplicor human immunodeficiency virus type 1 PCR and analysis of specimens with type 1 PCR with false-negative results. J Clin Microbiol. 1997;35:2846-2853.
3. Haas J, Geiss M, Bohler T. False-negative polymerase chain reaction-based diagnosis of human immunodeficiency virus type 1 in children infected with HIV strains of African origin. J Infect Dis. 1996;174:244-245.
4. Kline NE, Schwarwald H, Kline MW. False negative DNA polymerase chain reaction in an infant with subtype C HIV-1 infection. Pediatr Infect Dis J. 2002;21:885-886.
5. Zaman MM, Recco RA, Haag R. Infection with non-B subtype HIV type 1 complicates management of established infection in adult patients and diagnosis of infection in newborn infants. Clin Infect Dis. 2002;34:417-418.
6. Spira S. Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity, and drug resistance. J Antimicrob Chemother. 2003;51:229-240.
7. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available at: http://AIDSinfo.nih.gov. Accessed Dec 14, 2001.
8. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available at: http://AIDSinfo.nih.gov. Accessed Jan 20, 2004.
9. Antunes R, Figueiredo S, Bartolo I, et al. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms. J Clin Microbiol. 2003;41:3361-3367.
10. Plantier JC, Gueudin M, Damond F, Braun J, Mauclere P, Simon F. Plasma RNA quantification and HIV-1 divergent strains. J Acquir Immune Defic Syndr. 2003;33:1-7.
11. Geelen S, Lange J, Borleffs J, Wolfs T, Weersink A, Schuurman R. Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: a case of unexpected vertical transmission. AIDS. 2003;17:781-782.
12. Lyall EGH, Blott M, de Ruiter A, et al. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med. 2001;2:314-334.